Loading...
Derniers dépôts
-
Hubert Smeets, Bram Verbrugge, Xavier Bulbena, Liliya Hristova, Julia Vogt, et al.. European Joint Programme on Rare Diseases workshop: LAMA2-muscular dystrophy: paving the road to therapy March 17–19, 2023, Barcelona, Spain. LAMA2-muscular dystrophy: paving the road to therapy, Neuromuscular Disorders, 36, pp.16 - 22, 2024, ⟨10.1016/j.nmd.2024.01.001⟩. ⟨hal-04546346⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Pierre Joanne, Yeranuhi Hovhannisyan, Alexandre Simon, Gaëlle Revet, Romain Diot, et al.. Generation of human induced pluripotent stem cell lines from five patients with Myofibrillar myopathy carrying different heterozygous mutations in the DES gene. Stem Cell Research, 2024, 76, pp.103338. ⟨10.1016/j.scr.2024.103338⟩. ⟨hal-04466294⟩
-
Pascal Laforêt, Michio Inoue, Evelyne Goillot, Claire Lefeuvre, Umut Cagin, et al.. Deep morphological analysis of muscle biopsies from type III glycogenesis (GSDIII), debranching enzyme deficiency, revealed stereotyped vacuolar myopathy and autophagy impairment. Acta Neuropathologica Communications, 2019, 7 (1), ⟨10.1186/s40478-019-0815-2⟩. ⟨hal-02414161⟩
-
Florence Boisgérault, Amine Meliani, Romain Hardet, Solenne Marmier, Fanny Collaud, et al.. Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nature Communications, 2018, 9 (1), pp.4098. ⟨10.1038/s41467-018-06621-3⟩. ⟨hal-02177709⟩
-
Luce Barbat Du Closel, Nathalie Bonello-Palot, Yann Pereon, Andoni Echaniz-Laguna, Jean Philippe Camdessanche, et al.. Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease. European Journal of Neurology, 2023, 30 (10), pp.3265-3276. ⟨10.1111/ene.15937⟩. ⟨hal-04254200⟩
-
Lidia Almenara-Fuentes, Silvia Rodriguez-Fernandez, Estela Rosell-Mases, Katerina Kachler, Axel You, et al.. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine: Nanotechnology, Biology and Medicine, 2023, pp.102635. ⟨10.1016/j.nano.2022.102635⟩. ⟨hal-03885962⟩
Nombre de documents
773
Nombre de notices
1 376
widget_cloud
Treatment
OPMD
Clinical trials
Alternative splicing
Myotonic dystrophy type 1
Male
Regeneration
Heart
Duchenne muscular dystrophy
Genotype phenotype correlation
Trinucleotide repeat expansion
CRISPRi
Cancer
Neuromuscular diseases
Dermatomyositis
Astrocyte
Myotonic Dystrophy type 1
Lamin A/C LMNA gene
Biomarker
Myoblasts
Errance diagnostique
Therapy
Humans
FSHD
Muscular dystrophy
Animals
Glutamate
Autoantibodies
Myopathy
CTG repeat contractions
PABPN1
COVID-19
Congenital myopathy
Heart failure
Aged
Motoneuron
Fabry disease
LMNA
Satellite cells
RNA interference
Transgenic mouse model
Inflammation
Neuromuscular disease
ALS
Myositis
Thérapie génique
Dilated cardiomyopathy
Neuromuscular junction
Fibrosis
Thymus
Diagnosis
Centronuclear myopathy
Mouse model
Laminopathie
AAV
Cell therapy
Myasthenia gravis
Antisense oligonucleotides
Mechanotransduction
Nuclear envelope
Aging
Cardiomyopathy
Becker muscular dystrophy
DMD
Myogenesis
Calcium
Rare diseases
Satellite cell
Transcriptomics
LMNA gene
RNA biology
Lamin A/C
Myotonic Dystrophy
Brain
Gene therapy
Laminopathy
Laminopathies
Myopathies
Outcome measures
Autoimmunity
Myotonic dystrophy
Biomarkers
Rare neuromuscular diseases
Myasthenia Gravis MG
Dynamin 2
Dystrophin
Muscle regeneration
Congenital muscular dystrophy
Long read sequencing
Muscle
Skeletal muscle
Exercise
Actin
MBNL
Amyotrophic lateral sclerosis
Cytokines
Cytoskeleton
Autoimmune diseases
Autophagy
CMS